Abstract-Regression mechanism of Ethyl 2-(p-chlorophenoxy) isobutyratc (C11113) in the arterial wall was studied for elucidation in terms of fatty acid-compositional change in cholesterol-fed rabbits. The following evidence was obtained: (1) The amount of cholesterol and cholesteryl ester in the atheromatous aorta were reduced after CPIB treatment.
Abstract-Regression mechanism of Ethyl 2-(p-chlorophenoxy) isobutyratc (C11113) in the arterial wall was studied for elucidation in terms of fatty acid-compositional change in cholesterol-fed rabbits. The following evidence was obtained: (1) The amount of cholesterol and cholesteryl ester in the atheromatous aorta were reduced after CPIB treatment.
(2) CPIB resulted in a significant increase in the ratio of linoleate to oleate in both the arterial wall and serum after withdrawal of the cholesterol diet. It is suggested that there is a preferential hydrolysis of linoleate-rich cholesteryl ester in both the arterial wall and the serum.
The lipid-lowering activity of ethyl 2-(p-chlorophenoxy) isobutyrate (Clofibrate, CPIB)
has been well documented regarding rats (1-3), dogs, monkeys (4-5), and men (6) (7) (8) (9) (10) . The reduction mechanisms of the compound has been proposed to be: 1) enhancement of endogenous hormone activity, secondary to competition for binding sites on plasma proteins (2), 2) decrease in rate of fatty acid (FA) mobilization (11), 3) decrease in rate of hepatic cholesterol biosynthesis (11, 12) , 4) increase in rate of hepatic cholesterol oxidation (13), 5) decrease in rate of hepatic release of lipoproteins (14), 6) increase in rate of peripheral uptake of lipoproteins (15), 7) decrease in rate of fatty acid biosynthesis (16) . These mecha nisms in the atheromatous aorta remain to be clarified. In cholesterol-fed rabbits, Kri tchevsky et al. (17) and Feher et al. (18) also pointed out that CPIB produced significant reduction of cholesterol in arch atheroma but not so much in serum.
We have shown in previous papers (19, 20) that polyunsaturated FAs of cholesteryl ester (CE) might be preferentially hydrolyzed by CE-hydrolytic enzymes, and subsequently cholesterol might be eliminated from the tissues. FA-modification, such as increase in ratio of linoleate to oleate after CPIB treatment, may explain the reduction of cholesterol in the arterial wail.
The purpose of this study was an attempt to elucidate the mechanism of reduction of cholesterol in atheroma in terms of FA compositional improvement after CPIB treatment.
This is the first paper to describe an increase in ratio of linoleate to oleate in cholesterol fed rabbits treated with CPIB.
MAT[-TRIALS AND METHODS
G. 1'_1.61 g , CPIB group; 148.9---2.61 g). Blood samples were collected from an ear vein at 0, 15, and 30 days after withdrawal of the cholesterol diet. As a normal control, the samples were collected from rabbits before the cholesterol feeding. Thirty days after ingestion of the cholesterol diet, these animals were sacrificed and the aorta from the heart to the iliac bifurcation was removed. Preparation of homogenate from arterial intima was carried out according to the method described previously (20) . Quantitative analysis for FAs of CE were carried out by the method described previously (20) . Effect of'C'P/B on mount of Cholesterol, CL and F .A-composition of CE in atlreroniatous aorta: There is circumstantial evidence that the disease affects first the origin of the large vessels in the aortic arch, spreads therefrom to more extensive areas of the arch, later invades the thoracic aorta, and finally extends down to the abdominal aorta (25) . In this respect, repressive effect of CPIB on these three portions; arch, thoracic and abdominal aortas was examined. Table 1 shows that both cholesterol and CE decreased remarkably after CPIB administration particularly in the arch portions; about 31.3 , reduction in free and about 40.9;0' in CE were observed. In both thoracic and abdominal aorta, however, no regression was observed. In these portions, adventitia tissues were removed from intima only with great difficulty. These results suggested that, at least in the arch portion, CPIB induced a significant regression of cholesterol and CE after CPIB treatment.
To elucidate one of the mechanisms involved, FA-compositional change of CE in the arch was observed. reduction in cholesterol and CE over a 30 day period in both groups ( Table 3 ). The striking difference in FA-composition, however, was observed between the control and CPIB group.
As is shown in Table 4 and Fig. 2 , oleate was reduced more rapidly in the CPIB group than in the control (in C'P1B group, 71.4;0 of oleate and 74.9 linoleate and in control group, 58.3 of oleate and 80.1 "~ of linoleate was reduced for 30 days after withdrawal of cholesterol diet). Consequently, the ratio of linoleate to oleate in the C'PIB group gradually increased toward normal values. On the contrary, the ratio in the control group tended to decrease after discontinuation of the cholesterol diet (Fig. 3) . The reason why the ratio increased in the CPIB group may be due to the fact that the elimination rate of oleate was almost the same as that of linoleate, though, generally, linoleate is eliminated more rapidly than oleate in non-treated samples as was seen in the control group (Fig. 4) . These results indicate that the distribution of FA from the CPIB group appears to have a similar profile to that seen in normal serum. 
DISCUSSION
The present study indicates that ratio of linoleate to oleate of CE increased remarkably after the CPIB treatment in both serum and arterial wall of cholesterol-fed rabbits ( Table 2 , Fig. 3 ). It is well known that linoleate-rich CE can be hydrolyzed more preferentially by CE-hydrolytic enzymes than oleate (20, 26) . Therefore, linoleate may be more easily elimi nated from serum, arterial wall and other tissues. We suggested, herewith, that the im provement of FA-composition of CE might be one of the mechanisms of reduction of CPIB in addition to other functions of the compound.
Increase in the ratio of linolenate to oleate in serum after CPIB treatment may depend on the elimination rate of oleate as such was almost the same as that of linoleate in the CPIB group, though, generally, linoleate is more easily eliminated than oleate (20, 26) , as was shown in control groups (Fig. 4) . Distribution of FA-composition after CPIB treatment tended to have a similar profile with that of normal serum (Table 4 , Fig. 2 ).
Some investigators (26) (27) (28) pointed out that the ratio decreased in serum of human subjects after CPIB treatment. Bowyer et al. (30) stated that oleate may increase because of a preferential resistance of cholesteryl oleate to hydrolysis. Such indeed may be the case as the amount of cholesterol and CE in the serum decreased after the treatment in this particular case. These results, however, are contrary to our observations, obtained in cholesterol-fed rabbits. CPIB does not induce a significant reduction in cholesterol and CE of serum in rabbits on a cholesterol diet (31, 32) , though it does in human subjects.
Different effects of CPIB on the ratio in rabbit and human subjects may be explained by this reduction of cholesterol and CE of serum. Thus, CPIB may increase the ratio of linoleate to oleate. In the case of cholesterol-fed rabbits, linoleate-rich CE would be detected in this fraction, because the amount of cholesterol and CE of serum did not decrease even after CPIB treatment. On the contrary, in the case of human subjects, a significant decrease in cholesterol and CE occurs and' oleate-rich CE which is resistant to hydrolysis, therefore, would remain in the serum.
Considering the increase in the ratio in CE of arterial wall after CPIB treatment, it appears that 1) linoleate-rich lipoprotein, which increased in serum, may penetrate into the arterial wall, 2) in the arterial wall also, the elimination of oleate occurs at almost the same rate as that of linoleate. Consequently, ratio of linoleate to oleate might increase in athero matous aorta after the treatment.
If one compares the increase of ratio between serum and athermatous aorta, the increase in arterial wall was much less than that in the serum (Table 2 , Fig. 3 ). In the case of a theromatous aorta, CE was apparently accumulated as lipid crystals rich in oleate (ratio of linoleate to oleate is about 0.12) (20, 33) . Thus, oleate-rich lipid crystal (as solid phase)
may not be so readily hydrolyzed and the decrease of oleate was faster in the serum than in the arterial wall.
The improvement in terms of FA-composition, therefore, may be one plausible ex planation for this reduction mechanism of CPIB in atheroma: 1) linoleate-rich CE may be hydrolyzed more rapidly than oleate and free cholesterol might be excreted out from the arterial wall, 2) linoleate-rich CE from the arterial wall may be easily mobilized. Further studies are required to elucidate how the hydrolysis of oleate in serum occurred at almost the same rate as that of linoleate after CPIB treatment.
